DEF 14AThe Ballot
Acrivon Therapeutics, Inc. files DEF 14A
Filed May 1, 2023 · 3y ago · Accession 0000950170-23-016268
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Company
- Acrivon Therapeutics, Inc.
- Ticker
- ACRV
- CIK
- 1781174
- Form type
- DEF 14A
- Filing date
- May 1, 2023
- Report date
- Jun 22, 2023
- Document
- acrivon_proxy_2023.htm
- Size
- 3.7 MB